Financial News
Latest News about FATE
Recent news which mentions FATE
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
Cathie Wood Likes Fate Therapeutics, Should You?
December 01, 2021
From Motley Fool
3 Biotech Stocks That Can Double Your Money, According to Wall Street
November 25, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
November 09, 2021
From Benzinga
Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
FATE
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
3 Biotech Stocks to Watch Now
October 12, 2021
From Benzinga
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
September 14, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
From Benzinga
58 Biggest Movers From Friday
August 23, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 20, 2021
From Benzinga
38 Stocks Moving In Friday's Mid-Day Session
August 20, 2021
From Benzinga
Why Fate Therapeutics Stock Is Sliding Today
August 20, 2021
From Motley Fool
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 20, 2021
From Benzinga
11 Health Care Stocks Moving In Friday's Pre-Market Session
August 20, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response
August 20, 2021
Tickers
FATE
From Benzinga
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
From Benzinga
Fate Therapeutics, inc (FATE) Q2 2021 Earnings Call Transcript
August 06, 2021
Tickers
FATE
From Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
Did You See What Cathie Wood Bought on Wednesday?
July 22, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.